Title: |
Changes in hemodynamic parameters with the use of etomidate versus ketamine induction in the emergency department. |
Authors: |
Bakhsh, Abdullah1 aarbakhsh@kau.edu.sa, Alnashri, Maryam2, Alawami, Fatimah2, Aseel, Rafal2, Almaghthawi, Maha2, Alrahaili, Ghaida2, Bifari, Anas2, Algethami, Hassan2 |
Source: |
Signa Vitae. Mar2021, Vol. 17 Issue 2, p85-92. 8p. |
Subject Terms: |
*HEMODYNAMICS, *HOSPITAL emergency services, *KETAMINE, *SYSTOLIC blood pressure, *ETOMIDATE |
Abstract: |
Objectives: Etomidate is the sedative agent of choice during rapid sequence intubation (RSI) owing to its hemodynamic stability, rapid onset of action, and short duration of action. Nevertheless, ketamine is rapidly gaining popularity as an alternative agent, primarily because of its catecholamine-mediated effects. This feature has prompted clinicians to use ketamine for hemodynamically unstable patients. The aim of this study was to compare the percent change in hemodynamic parameters resulting from the use of etomidate versus ketamine during RSI in the emergency department. Methods: This cross-sectional prospective observational study conducted at an academic emergency department included patients recruited from March 2018 through May 2019 on a convenience basis when the principal investigator was scheduled to work in the emergency department. Results: Our study showed a percent reduction in all hemodynamic parameters with the use of ketamine: -13.14% in systolic blood pressure, -10.40% in diastolic blood pressure, -10.15% in mean arterial pressure, and -1.12% in heart rate. Moreover, the rate of ≥ 20% reduction in hemodynamic parameters with ketamine was 27.27% in systolic blood pressure, 18.18% in diastolic blood pressure, 18.18% in mean arterial pressure, and 27.27% in heart rate. Conclusions: Although ketamine has a sympathomimetic effect, it may cause hemodynamic instability in select patients. Therefore, caution is advised when using ketamine routinely during RSI, especially in critically ill patients in the emergency department. [ABSTRACT FROM AUTHOR] |
|
Copyright of Signa Vitae is the property of Pharmamed Mado Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
Database: |
Academic Search Complete |